Back
Clearside Biomedical Vs. Corvus Pharmaceuticals Industry Stock Comparison
Sell
31
CLSD
Clearside Biomedical
Last Price:
1.06
Seasonality Move:
25.1%
Buy
58
CRVS
Corvus Pharmaceuticals
Last Price:
9.12
Seasonality Move:
-3.9%
Sell
31
Clearside Biomedical (CLSD)
is a Sell
Is Clearside Biomedical a Buy, Sell or Hold?
- The current Clearside Biomedical [CLSD] share price is $1.02. The Score for CLSD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CLSD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy, Sell or Hold?
- The current Corvus Pharmaceuticals [CRVS] share price is $8.94. The Score for CRVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLSD Stock Price Chart
What is Clearside Biomedical's stock price today?
-
The Clearside Biomedical share price today is $1.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLSD is experiencing selling pressure, which indicates risk of future bearish movement.
CRVS Stock Price Chart
What is Corvus Pharmaceuticals's stock price today?
-
The Corvus Pharmaceuticals share price today is $8.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLSD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 42.23 | Sell |
| Chaikin Money Flow: | -160613 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.15) | Sell |
| Bollinger Bands (100): | (1.02 - 1.26) | Sell |
CRVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 60.34 | Buy |
| Chaikin Money Flow: | 638494 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.94 - 9.14) | Buy |
| Bollinger Bands (100): | (2.78 - 7.48) | Buy |
CLSD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.04 | Sell |
| 20-day SMA: | 1.06 | Sell |
| 50-day SMA: | 1.18 | Sell |
| 200-day SMA: | 1.25 | Sell |
| 8-day EMA: | 1.04 | Sell |
| 20-day EMA: | 1.08 | Sell |
| 50-day EMA: | 1.12 | Sell |
| 200-day EMA: | 1.19 | Sell |
CRVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.53 | Buy |
| 20-day SMA: | 8.78 | Buy |
| 50-day SMA: | 7.1 | Buy |
| 200-day SMA: | 3.54 | Buy |
| 8-day EMA: | 8.6 | Buy |
| 20-day EMA: | 8.41 | Buy |
| 50-day EMA: | 7.24 | Buy |
| 200-day EMA: | 4.34 | Buy |
Clearside Biomedical Earnings Growth & CLSD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.00 per share.
Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.
Clearside Biomedical Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corvus Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||